PDS Biotechnology Corp To Host Key Opinion Leader Roundtable Transcript

Oct 03, 2023 / 12:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and we do thank you for your patience today. Welcome to the PDS Biotechnology webcast, Current and Future Treatments for Recurrent/Metastatic HPV-Positive Head and Neck Cancer. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Dr. Lauren Wood. Dr. Wood, please go ahead.

Lauren V. Wood - PDS Biotechnology Corporation - Chief Medical Officer

Thank you, Kevin. Good morning, everyone, and welcome to PDS Biotech's Current and Future Treatments for Recurrent/Metastatic HPV-Positive Head and Neck Cancer and the Potential Application of PDS0101 KOL Web Roundtable Webinar. Again, we apologize for the delay.

With me today are Dr. Ricard Mesia from the Catalan Institute of Oncology; Dr. John Kaczmar from the Medical University of South Carolina; Dr. Katharine Price from Mayo Clinic Comprehensive Cancer Center; and Dr. Glenn Hanna from Dana-Farber Cancer Institute.

I will provide formal introductions in a moment, but before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot